Open Beta
MetriLume

US marketsBGLC

SEC-sourced researchBeta

BGLC

BioNexus Gene Lab Corp

Company comparison ↗

Data passport

CIK
0001737523
Exchange
Nasdaq
Business activity
Services-Medical Laboratories · SIC 8071
Financial inputs
6/6
Filing date
Nov 19, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 9,510,646.0000 USD; December 2025: 7,424,911.0000 USD9.5M USD0 USD0December 2024December 2025
BGLC · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20249,510,646.0000Apr 14, 2026
December 20257,424,911.0000Apr 14, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20257,424,911.0000-2,984,607.0000-1,838,382.00009,252,784.0000637,856.0000Apr 14, 2026
December 20249,510,646.0000-1,598,342.0000-2,093,260.000010,433,848.00002,111,044.0000Apr 14, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

44/100
Profitability0
Growth28
Balance sheet93
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$7.42MJan 1, 2025 – Dec 31, 2025Apr 14, 202610-K
Previous period revenueRevenues$9.51MJan 1, 2024 – Dec 31, 2024Apr 14, 202610-K
Net incomeNetIncomeLoss-$2.98MJan 1, 2025 – Dec 31, 2025Apr 14, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$1.84MJan 1, 2025 – Dec 31, 2025Apr 14, 202610-K
Total assetsAssets$9.25MDec 31, 2025Apr 14, 202610-K
Total liabilitiesLiabilities$637.86KDec 31, 2025Apr 14, 202610-K

New filings

Explore methodology ↗